334
Views
7
CrossRef citations to date
0
Altmetric
Review

Dengue fever in Europe: could there be an epidemic in the future?

&

References

  • Thai KT, Anders KL. The role of climate variability and change in the transmission dynamics and geographic distribution of dengue. Exp Biol Med (Maywood) 2011;236(8):944-54
  • WHO. Dengue and dengue haemorrhagic fever. Factsheet Nº117, may 2008. Geneva, World Health Organization. 2008. Available from: www.who.int/mediacentre/factsheet/fs117/en/
  • Bhatt S, Gething PW, Brady OJ, et al. The global distribution and burden of dengue. Nature 2013;496(7446):504-7
  • Suaya JA, Sheprd DS, Beatty ME. Dengue burden of disease and costs of illness. Working paper 3.2 in: Report of the Scientific Working Group meeting on Dengue, Geneva, 1-5 October 2006, Special Programme for Research and Training in Tropical Diseases. World Health Organization, Geneva, Genebra, Suiça 2007
  • Amarasinghe A, Kuritsk JN, Letson GW, Margolis HS. Dengue virus infection in Africa. Emerg Infect Dis 2011;17(8):1349-54
  • Günther J, Martínez-Muñoz JP, Pérez-Ishiwara DG, Salas-Benito J. Evidence of vertical transmission of dengue virus in two endemic localities in the state of Oaxaca, Mexico. Intervirology 2007;50(5):347-52
  • Murray NE, Quam MB, Wilder-Smith A. Epidemiology of dengue: past, present and future prospects. Clin Epidemiol 2013;20:5:299-309
  • Wilder-Smith A, Gubler DJ. Geographic expansion of dengue: the impact of international travel. Med Clin North Am 2008;92(6):1377-90
  • Al-Muhandis N, Hunter PR. The value of educational messages embedded in a community-based approach to combat dengue Fever: a systematic review and meta regression analysis. PloS Negl Trop Dis 2011;5(8):e1278
  • Vasilakis N, Weaver SC. The history and evolution of human dengue emergence. Adv Virus Res 2008;72:1-76
  • Chen R, Vasilakis N. Dengue–quo tu et quo vadis? Viruses 2011;3(9):1562-608
  • Reiter P. Yellow fever and dengue: a threat to Europe? Euro Surveill 2010;15(10):19509
  • Weaver SC, Reisen WK. Present and future arboviral threats. Antiviral Res 2010;85(2):328-45
  • Rao BB, Harikumar PS, Jayakrishnan T, George B. Characteristics of Aedes(Stegomyia) albopictusSkuse (Diptera:culicidae) breeding sites. Southeast Asian J Trop Med Public Health 2011;42(5):1077-82
  • Lounibos LP. Invasions by insect vectors of human disease. Annu Rev Entomol 2002;47:233-66
  • Wang E, Ni H, Xu R, et al. Evolutionary relationships of endemic/epidemic and sylvatic dengue viruses. J Virol 2000;74(7):3227-34
  • Heinz FX, Stiasny K. Flaviviruses and flavivirus vaccines. Vaccine 2012;30(29):4301-6
  • Normile D. Tropical medicine. Surprising new dengue virus throws a spanner in disease control efforts. Science 2013;342(6157):415
  • Franco L, Palacios G, Martinez JÁ, et al. First report of sylvatic DENV-2-associated dengue hemorrhagic fever in West Africa. PloS Negl Trop Dis 2011;5(8):e1251
  • Rudnick A. Dengue virus ecology in Malaysia. Inst Med Res Malays Bull 1986;23:51-152
  • Diallo M, Ba Y, Sall AA, et al. Amplification of the sylvatic cycle of dengue virus type 2, Senegal, 1999-2000: entomologic findings and epidemiologic considerations. Emerg Infect Dis 2003;9(3):362-7
  • Mattingly PF. Genetical aspects of the Aedesaegypti problem. I. Taxonom: and bionomics. Ann Trop Med Parasitol 1957;51(4):392-408
  • Vasilakis N, Cardosa J, Hanley KA, et al. Fever from the forest: prospects for the continued emergence of sylvatic dengue virus and its impact on public health. Nat Rev Microbiol 2011;9(7):532-41
  • Powell JR, Tabachnick WJ. History of domestication and spread of Aedesaegypti - A Review. Mem Inst Oswaldo Cruz 2013;108(Suppl 1):11-17
  • Freire JM, Veiga AS, Torre BG, et al. Peptides as models for the structure and function of viral capsid proteins: insights on dengue virus capsid. Biopolymers 2013;100(4):325-36
  • Zhang X, Sheng J, Plevka P, et al. Dengue structure differs at the temperatures of its human and mosquito hosts. Proc Natl Acad Sci USA 2013;110(17):6795-9
  • Diallo M, Sall AA, Moncayo AC, et al. Potential role of sylvatic and domestic African mosquito species in dengue emergence. Am J Trop Med Hyg 2005;73(2):445-9
  • deThoisy B, Lacoste V, Germain A, et al. Dengue infection in neotropical forest mammals. Vector Borne Zoonotic Dis 2009;9(2):157-70
  • Roberts DR, Peyton EL, Pinheiro FP, et al. Associations of arbovirus vectors with gallery forests and domestic environments in southeastern Bolivia. Bull Pan Am Health Organ 1984;18(4):337-50
  • Rosen L, Roseboom LE, Gubler DJ, et al. Comparative susceptibility of mosquito species and strains to oral and parenteral infection with dengue and Japanese encephalitis viruses. Am J Trop Med Hyg 1985;34(3):603-15
  • Gratz NG. Critical review of the vector status of Aedes albopictus. Med Vet Entomol 2004;18(3):215-27
  • Scott TW, Takken W. Feeding strategies of anthropophilic mosquitoes result in increased risk of pathogen transmission. Trends Parasitol 2012;28(3):114-21
  • Randolph SE, Rogers DJ. The arrival, establishment and spread of exotic diseases: patterns and predictions. Nat Rev Microbiol 2010;8(5):361-71
  • Christophers SR. Aedesaegypti (L.), the Yellow Fever mosquito. Cambridge University Press; London, UK: 1960
  • Chang LH, Hsu EL, Teng HJ, Ho CM. Differential survival of Aedesaegypti and Aedesalbopictus (Diptera: culicidae) larvae exposed to low temperatures in Taiwan. J Med Entomol 2007;44(2):205-10
  • Capinha C, Rocha J, Sousa CA. Macroclimate determines the global range limit of Aedesa egypti. EcoHealth 2014;11(3):420-8
  • Bouzid M, Colón-González FJ, Lung T, et al. Climate change and the emergence of vector-borne diseases in Europe: case study of dengue fever. BMC Public Health 2014;14(1):781
  • Hawley WA. The biology of Aedesalbopictus. J Am Mosq Control Assoc 1988;1:1-39
  • Medlock JM, Hansford KM, Schaffner F, et al. A review of the invasive mosquitoes in Europe: ecology, public health risks, and control options. Vector Borne Zoonotic Dis 2012;12(6):435-47
  • WHO. Dengue: guidelines for diagnosis, treatment, prevention and control. World Health Organization; Geneva, Switzerland: 2009
  • WHO. Handbook of clinical management of dengue. World Health Organization; Geneva, Switzerland: 2012
  • CDC. Available from: www.cdc.gov/dengue/faqFacts/fact.html2012
  • Halstead SB. Etiologies of the experimental dengues of Siler and Simmons. Am J Trop Med Hyg 1974;23(5):974-82
  • Nishiura N. Duration of short-lived cross-protective immunity against a clinical attack of dengue. A preliminary estimate. Dengue Bull 2008;32:55-66
  • Pang T, Cardosa MJ, Guzmán MG. Of cascades and perfect storms: the immunopathogenesis of dengue haemorrhagic fever-dengue shock syndrome (DHF/DSS). Immunol Cell Biol 2007;85(1):43-5
  • Guzman MG, Kouri G. Dengue haemorrhagic fever integral hypothesis: confirming observations, 1987-2007. Trans R Soc Trop Med Hyg 2008;102(6):522-3
  • Halstead SB, Streit TG, Lafontant JG, et al. Haiti: absence of dengue hemorrhagic fever despite hyperendemic dengue virus transmission. Am J Trop Med Hyg 2001;65(3):180-3
  • Messer WB, Gubler DJ, Harris E, et al. Emergence and global spread of a dengue serotype 3, subtype III virus. Emerg Infect Dis 2003;9(7):800-9
  • Lan NT, Hirayama K. Host genetic susceptibility to severe dengue infection. Trop Med Health 2011;39(4 Suppl):73-81
  • Rothman AL. Immunity to dengue virus: a tale of original antigenic sin and tropical cytokine storms. Nat Rev Immunol 2011;11(8):532-43
  • Guzman MG, Kourí G, Valdés L, et al. Enhanced severity of secondary dengue-2 infections: death rates in 1981 and 1997 Cuban outbreaks. Rev Panam Salud Publica 2002;11(4):223-7
  • Guzman MG, Alvarez M, Halstead SB. Secondary infection as a risk factor for dengue hemorrhagic fever/dengue shock syndrome: an historical perspective and role of antibody-dependent enhancement of infection. Arch Virol 2013;158(7):1445-59
  • Jessie K, Fong MY, Devi S, et al. Localization of dengue virus in naturally infected human tissues, by immunohistochemistry and in situ hybridization. J Infect Dis 2004;189(8):1411-18
  • Flipse J, Wilschut J, Smit JM. Molecular mechanisms involved in antibody-dependent enhancement of dengue virus infection in humans. Traffic 2013;14(1):25-35
  • Moi ML, Takasaki T, Saijo M, Kurane I. Dengue virus infection-enhancing activity of undiluted sera obtained from patients with secondary dengue virus infection. Trans R Soc Trop Med Hyg 2013;107(1):51-8
  • Goncalvez AP, Engle RE, St Claire M, et al. Monoclonal antibody-mediated enhancement of dengue virus infection in vitro and in vivo and strategies for prevention. Proc Natl Acad Sci USA 2007;104(22):9422-7
  • Balsitis SJ, Williams KL, Lachica R, et al. Lethal antibody enhancement of dengue disease in mice is prevented by Fc modification. PloS Pathog 2010;6(2):e1000790
  • Simmons CP, Chau TN, Thuy TT, et al. Maternal antibody and viral factors in the pathogenesis of dengue virus in infants. J Infect Dis 2007;196(3):416-24
  • Ng JK, Zhang SL, Tan HC, et al. First experimental in vivo model of enhanced dengue disease severity through maternally acquired heterotypic dengue antibodies. PloS Pathog 2014;10(4):e1004031
  • Dalrymple NA, Mackow ER. Virus interactions with endothelial cell receptors: implications for viral pathogenesis. Curr Opin Virol 2014;7C:134-40
  • Salgado DM, Eltit JM, Mansfield K, et al. Heart and skeletal muscle are targets of dengue virus infection. Pediatr Infect Dis J 2010;29(3):238-42
  • Muller DA, Young PR. The flavivirus NS1 protein: molecular and structural biology, immunology, role in pathogenesis and application as a diagnostic biomarker. Antiviral Res 2013;98(2):192-208
  • Teixeira RR, Pereira WL, Oliveira AF, et al. Natural products as source of potential dengue antivirals. Molecules 2014;19(6):8151-76
  • Noble CG, Shi PY. Structural biology of dengue virus enzymes: towards rational design of therapeutics. Antiviral Res 2012;96(2):115-26
  • Lee HC, Butler M, Wu SC. Using recombinant DNA technology for the development of live-attenuated dengue vaccines. Enzyme Microb Technol 2012;51(2):67-72
  • Sabchareon A, Wallace D, Sirivichayakul C, et al. Protective efficacy of the recombinant, live-attenuated, CYD tetravalent dengue vaccine in Thai school children: a randomised, controlled phase 2b trial. Lancet 2012;380(9853):1559-67
  • Capeding MR, Tran NH, Hadinegoro SR, et al. Clinical efficacy and safety of a novel tetravalent dengue vaccine in healthy children in Asia: a phase 3, randomised, observer-masked, placebo-controlled trial. Lancet 2014;384(9951):1358-65
  • Holstein M. Dynamics of Aedesaegypti distribution, density and seasonal prevalence in the Mediterranean area. Bull World Health Organ 1967;36(4):541-3
  • VBORNET. Available from: www.ecdc.europa.eu/en/healthtopics/vectors/vector-maps/Pages/VBORNET_maps.aspx
  • Almeida AP, Gonçalves YM, Novo MT, et al. Vector monitoring of Aedesaegypti in the Autonomous Region of Madeira, Portugal. Euro Surveill 2007;12(11):E071115.6
  • Almeida AP, Freitas FB, Novo MT, et al. Mosquito surveys and West Nile virus screening in two different areas of southern Portugal, 2004-2007. Vector Borne Zoonotic Dis 2010;10(7):673-80
  • Comunicado do diretor-geral da saúde sobre casos de dengue na região autónoma da Madeira 2012. 2012. Available from: www.dgs.pt/?mid=0&cr=23048, 03.10.2012
  • DGS, 2013. Surto de dengue na Ilha da Madeira - situação em 3 de março de 2013. Informação mensal sobre dengue na Ilha da Madeira. Available from: www.dgs.pt/ficheiros-de-upload-2013/dengue-madeira-situacao-em-2013_03_03-pdf.aspx
  • Alves MJ, Fernandes PL, Amaro F, et al. Clinical presentation and laboratory findings for the first autochthonous cases of dengue fever in Madeira island, Portugal, October 2012. Euro Surveill 2013;18(6):20398
  • Wilder-Smith A, Quam M, Sessions O, et al. The 2012 dengue outbreak in Madeira: exploring the origins. Euro Surveill 2014;19(8):20718
  • Rezza G, Nicoletti L, Angelini R, et al. Infection with chikungunya virus in Italy: an outbreak in a temperate region. Lancet 2007;370(9602):1840-6
  • Louis C. Daily newspaper view of dengue fever epidemic, Athens, Greece, 1927-1931. Emerg Infect Dis 2012;18(1):78-82
  • Ruche G, Souarès Y, Armengaud A, et al. First two autochthonous dengue virus infections in metropolitan France, September 2010. Euro Surveill 2010;15(39):19676
  • Gjenero-Margan I, Aleraj B, Krajcar D, et al. Autochthonous dengue fever in Croatia, August-September 2010. Euro Surveill 2011;16(9):19805
  • Kurolt IC, Betica-Radić L, Daković-Rode O, et al. Molecular characterization of dengue virus 1 from autochthonous dengue fever cases in Croatia. Clin Microbiol Infect 2013;19(3):E163-5
  • Available from: www.invs.sante.fr/Dossiers-thematiques/Maladies-infectieuses/Maladies-a-transmission-vectorielle/Chikungunya/Donnees-epidemiologiques/France-metropolitaine/Chikungunya-et-dengue-Donnees-de-la-surveillance-renforcee-en-France-metropolitaine-en-2014 [Last accessed 22 October 2014]
  • Marchand E, Prat C, Jeannin C, et al. Autochthonous case of dengue in France, October 2013. Euro Surveill 2013;18(50):20661
  • Jelinek T. Trends in the epidemiology of dengue fever and their relevance for importation to Europe. Euro Surveill 2009;14(25):19250
  • Robert Koch Institute. Available from: http://www3.rki.de/SurvStat [Last accessed 23 January 2014]
  • Parreira R, Centeno-Lima S, Lopes A, et al. Dengue virus serotype 4 and chikungunya virus coinfection in a traveller returning from Luanda, Angola, January 2014. Euro Surveill 2014;19(10):20730
  • ECDC. Development of Aedesalbopictus risk maps. 2009. Available from: www.ecdc.europa.eu/en/publications/publications/0905_ter_development_of_aedes_albopictus_risk_maps.pdf
  • ECDC. The climatic suitability for dengue transmission in continental Europe. 2012 Available from: file:///F:/Dengue/PDFs/ter-climatic-suitablility-dengue.pdf
  • Mulyatno KC, Yamanaka A, Yotopranoto S, Koshini E. Vertical transmission of dengue virus in Aedesaegypti collected in Surabaya, Indonesia, during 2008-2011. Jpn J Infect Dis 2012;65(3):274-6
  • Martins VE, Alencar CH, Kamimura MT, et al. Occurrence of natural vertical transmission of dengue-2 and dengue-3 viruses in Aedesaegypti and Aedesalbopictus in Fortaleza, Ceará, Brazil. PLoS One 2012;7(7):e41386
  • DGS, 2014a. Surto de dengue na Ilha da Madeira - situação em 19 de maio de 2013. Informação mensal sobre dengue na Ilha da Madeira. Available from: http://www.dgs.pt/ficheiros-de-upload-2013/dengue-madeira-situacao-em-2013_03_03-pdf.aspx
  • DGS, 2014b. Surto de dengue na Ilha da Madeira - situação em 1 de setembro de 2013. Informação mensal sobre dengue na Ilha da Madeira. Available from: http://www.dgs.pt/ficheiros-de-upload-2013/dengue-madeira-situacao-em-2013_03_03-pdf.aspx
  • Seixas G, Salgueiro P, Silva AC, et al. Aedesaegypti on Madeira Island (Portugal): genetic variation of a recently introduced dengue vector. Memórias do Instituto Oswaldo Cruz 2013;108(Supl 1):1-8
  • Rogers DJ, Suk JE, Semenza JC. Using global maps to predict the risk of dengue in Europe. Acta Trop 2014;129:1-14
  • Straetemans M; ECDC Consultation Group on Vector-Related Risk for Chikungunya Virus Transmission in Europe. Vector-related risk mapping of the introduction and establishment of Aedesalbopictus in Europe. Euro Surveill 2008;13(7):8040
  • Schaffner F, Medlock JM, Van Bortel W. Public health significance of invasive mosquitoes in Europe. Clin Microbiol Infect 2013;19(8):685-92
  • Becker N, Geier M, Balczun C, et al. Repeated introduction of Aedesalbopictus into Germany, July to October 2012. Parasitol Res 2013;112(4):1787-90
  • Vega-Rua A, Zouache K, Caro V, et al. High efficiency of temperate Aedesalbopictus to transmit chikungunya and dengue viruses in the Southeast of France. PLoS One 2013;8(3):e59716
  • Castro M, Sánchez L, Pérez D, et al. The relationship between economic status, knowledge on dengue, risk perceptions and practices. PLoS ONE 2013;8(12):e81875
  • Sanchez L, Perez D, Cruz G, et al. Intersectoral coordination, community empowerment and dengue prevention: six years of controlled interventions in Playa Municipality, Havana, Cuba. Trop Med Int Health 2009;14(11):1356-64
  • Nazareth T, Teodósio R, Porto G, et al. Strengthening the perception-assessment tools for dengue prevention: a cross-sectional survey in a temperate region (Madeira, Portugal). BMC Public Health 2014;14:39

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.